Table 1 Membranes in OOC studies, characteristics, and applications
From: Polymeric and biological membranes for organ-on-a-chip devices
Membrane material | Application study | Fluidic flow/shear stress | Stimuli | Fabrication method/provider, bonding | Thickness | Porosity diameter; center-to-center/density | Biological coating |
|---|---|---|---|---|---|---|---|
PDMS | Gut: Recapitulation of intestine Coculture with L. rhamnosus41 | 30 mL/h 0.02 dyne/cm2 | Cyclic strain (10%; 0.15 Hz) | Soft lithography (casting on a microfabricated silicon wafer from MEMS and Nanotechnology Exchange) Oxygen plasma | 30 μm | 10 µm; 25 µm | Matrigel® and collagen Type I (Caco-2) |
PDMS | Small intestine: Biopsy-derived epithelium cultured on-chip for transcriptomic comparison; duodenum-like118 | 60 μl/h | Strain (10%; 0.2 Hz) | Both fabricated (Kim 2012 soft lithography) & purchased from Emulate, Inc. Oxygen plasma | 50 μm | 7 μm; 40 μm | Matrigel® and collagen Type I (HIMECs) |
PDMS | Gut: Transepithelial barrier structure and tissue structure (impedance spectroscopy)117 | 30 μl/hr. 4.1 × 10−4 dyne/cm2 (41 μPa) | Electrical stimulation AC current of 10 μA at 50 frequencies in the range of 100–10 Hz | Kim 2012–soft lithography (casting on a microfabricated silicon wafer) Oxygen plasma | 50 μm | 7 μm; 40 μm | Matrigel® and collagen Type I (Caco-2) |
PDMS | Intestine: Host-microbiome interactions33 | 60 μl/hr. | N/A | Huh 2013 - silicon wafer using photolithography, removing silicon by DRIE. Obtained from MEMS and Nanotechnology Exchange Organ Chip (Emulate Inc.) Oxygen plasma | 10 μm | 10 µm; 25 µm | Matrigel® and collagen Type I (Caco-2, HIMECs) |
PDMS | Kidney: coculture of primary glomerular endothelial and hiPS-derived podocyte Recapitulation of glomerulus, selective permeability43 | 60 μL/h Top channel: 0.0007 dyne/cm2 Bottom channel: 0.017 dyne/cm2 | Cyclic strain (10%; 1 Hz, −85 kPa) | Huh, 2010. Stereolithography molds (ProtoLabs) and spincoating Oxygen plasma | 50 μm | 7 μm; 40 μm | Laminin (hiPS-derived podocytes) |
PDMS | Alveolus: Thrombosis model Primary human lung alveolar epithelial cells culture, human whole blood used. Evaluation of therapeutic alternative: protease activated receptor-1 (PAR-1) antagonist.24 | Wall shear rate ~10 dyne/cm2 (250 s−1) | N/A | Casting against DRIE silicon wafer Oxygen plasma | 50 μm | 7 μm; 40 μm | Collagen I, fibronectin (Primary alveolar cells, HUVECs) |
PDMS | Gut: Independent control of fluid flow and mechanical deformations to explore the influence of each in morphogenesis34 | 30 mL/h | Cyclic strain (10%; 0.15 Hz) | Kim 2012–soft lithography (casting on a microfabricated silicon wafer) Oxygen plasma | 20 μm | 10 µm; 25 µm | Matrigel® and collagen Type I (Caco-2) |
PDMS | Alveolus: Replication of breathing motion, air‒blood barrier and air-liquid interface Coculture: primary human lung alveolar cells (hAEpCs) and primary lung endothelial cells48 | N/A | Cyclic strain (0.2 Hz) | Microstructuring-lamination Oxygen plasma | 3.5 μm | 3 µm; 800,000 pores/cm2 | Collagen IV (epithelial cell line, 16HBE14o), collagen I (primary cell line, hAEpC) |
PDMS | Lung: Replication of idiopathic pulmonary fibrosis (IPF), pathological study on wound healing Treatment with recombinant human hepatic growth factor (rhHGF)4 | N/A | Cyclic strain (10%; 0.2 Hz) | Microstructuring-lamination Clamping (sandwich) | 3.5 μm | 3 µm; 800,000 pores/cm2 | Fibronectin (A549 epithelial cells) |
PDMS | Vessel: Coculture of aortic endothelial cells (ECs) and human aortic vascular smooth muscle cells (VSMCs) Mimicking of arterial wall44 | 20 μl/min shear stress of 1–1.5 Pa and strain of 5–8% | Pressure flow: 1 mbar/h increments until 15 mbar ( ≈ 1–1.5 Pa endothelial shear stress) Vacuum pressure −10 mbar/hr. steps until −200 mbar | Laser excimer (UV) Oxygen plasma (asher) | 10 μm | 10 µm; 28 µm | Fibronectin (ECs- HaVECs, VSMCs- hAoSMCs) |
PDMS | Microfluidic device: Combine temperature, pressure, and moisture to generate micron-scale pores on a PDMS membrane. Relate those parameters with pore size and adhesion to DNA, and collagen.79 | 20 μl/min | N/A | High-pressure saturated steam Thermal treatment | 40 μm | 5 µm | Parylene-C, collagen (platelets) |
PDMS | Organ-on-a-chip: Viability of cell culturing: Human umbilical endothelial cells (HUVEC) and MDA-MB-231 (MDA) cells14 | N/A | N/A | Photolithography, dry and wet etching PDMS/toluene mortar; Oxygen plasma | 1–4 μm | 2–10 μm; 8–65% | Fibronectin (HUVEC-primary, MDA-cancer) |
SiO2 | Chip: Ultrathin membrane for support of physiologically relevant cellular interactions Optically transparent Human umbilical vein endothelial cells (HUVECs) spread and proliferate on these membranes.69 | N/A | N/A | Photolithography and reactive ion etching Ozone | 300 nm (comparable in thickness to the vascular basement membrane of 100–300 nm) | 0.5 and 3 μm; 27.5% | Geltrex (Life Technologies, California) HUVECs |
PLGA | Lung tumor: Gefitinib drug testing Permeability, coculture1 | N/A | N/A | Electrospinning PLGA direct sealing | 3 μm | NA, nanofiber | (A549 epithelial cells) |
Collagen-elastin | Lung: Air‒blood barrier replication, exposed to mechanical forces Gold mesh to mimic alveolar size and structure3 | N/A | Strain 10%; 4.0 kPa | Gelation Double tape | 10 μm | hAEpCs (primary cells) | |
Collagen | Kidney: Endothelial-epithelial exchange interface, reabsorption mechanism137 | 10 µl/min Wall shear stress ~1–10 dyne/cm2 | N/A | Compression molding Screwing | 25 μm | NA | hRVTU, HUVECs |
Collagen | Colon: Suitability of membrane for OOC, comparison w/Transwell ® Microstructure, transport and cell viability136 | N/A, media changed daily | N/A | Lyophilization Sandwiching | ~15 μm | ~10.2 μm | Caco-2 |
Collagen | Microfluidic device: Cell attachment, growth physiologically relevant in vitro cell culture models19 | 70–100 µl/hr. | N/A | Vitrification PDMS mortar | 20 μm | 250 nm | HUVECs |
PDMS* | Colon: Mucus layer physiology119 | 60 µl/hour | N/A | CHIP-S1 Stretchable Chip, RE00001024 Basic Research 1680 Kit; Emulate, Inc | 50 μm | 7 μm; 40 μm | Matrigel® and collagen Type I (primary colonic intestinal epithelial cells) |
PDMS* | Spinal cord: Vascular-neural interaction Specific gene activation enhanced neuronal function and in vivo-like signatures.102 | N/A | N/A | Emulate, Inc. | 50 μm | 7 μm; 40 μm | Matrigel® (neural, spMNs) Collagen IV and fibronectin (vascular, BMECs) |
Polyester* | Intestine: Long-term culture up to 30 days Rhohdamine 123 basal to apical flow103 | N/A | Magnetic stir bar to pump media | Corning (Transwell ®) Oxygen plasma | 10 μm | 0.4 μm | Type I collagen (Caco-2) |
Polyester* | Kidney: Primary rat inner medullary collecting duct (IMCD) cells115 Primary kidney epithelial cells Enhanced epithelial cell polarization and primary cilia formation. Cisplatin toxicity and Pgp efflux transporter activity measured on-chip.110 | 0.2 dyne/cm2 (physiological conditions renal system: 0.2–20 dyne/cm2, ~10% of the endothelial cell) 1 dyne/cm2 for 5 h | N/A | Corning (Transwell ®) Oxygen plasma | 10 μm | 0.4 μm | Fibronectin, Collagen Type IV (PTEpiC, primary) |
PET* | Gut: Immune response, microbial pathogenicity mechanisms, and quantification of cellular dysfunction Probiotic L. rhamnosus Pathogen Candida albicans161 | Flow rate: 50 μl/min Endothelial: 0.07 Pa Luminal: 0.01 Pa | N/A | TRAKETCH Sabeu, Radeberg, Germany Polystyrol (PS) foil (microfluidic ChipShop, Germany) | 12 μm | 8 μm; 1 × 105 pores/cm2 | HUVECs, Caco-2 |
PET* | Gut: Transport study of amoxicillin, antipyrine, ketoprofen and digoxin27 | 100 μL/h | N/A | N/A Clamping | 12 μm | 0.4 μm; 1.6 × 106 pore density | Caco-2 |
PET* | Small intestine-Liver: Caco-2, HepG2, and A549 cell cultures were used as organ models of the small intestine, liver, and lung, respectively. Pharmacokinetics: —epirubicine (EPI), irinotecan (CPT-11), and cyclophosphamide (CPA)104 | Rotation frequency of 1600 rpm to generate a flow rate of 0.16 µL/s | N/A | N/A Oxygen plasma | -- | -- | Collagen (Caco-2, HepG2) |
PET* | Heart: Centrifugally assisted cell loading50 | Flow rate: 50 µL/h | Centrifugation (3 min at 138 · g) | SABEU 030444 Oxygen plasma | 3 μm | -- | Fibronectin (hiPSC-derived CMs) |
Teflon* | Gut: Electrodes for transepithelial electrical resistance (TEER) measurements for real-time monitoring of barrier integrity Permeability studies to evaluate differentiation. Mucus production116 | Day 1 flow rate of 0.5 μl/min, upper layer Day 2 onward 3 μl/min, both chambers, shear stress ~ 0.008 dyne/cm2 at (Physiological conditions epithelial cells: 1 to 5 dyne/cm2) | N/A | Millipore, Denmark UV radiation | 40 μm | 0.4 μm; ~ 75% | Matrigel® and collagen Type I (Caco-2) |
PC* | Lung: 3D culture-specific-morphology, maintained excellent barrier integrity, secreted mucus, and expressed cell surface functional P-glycoprotein Effects of cigarette smoke extract (CSE) on Interleukin-6 (IL-6) and Interleukin-8 (IL-8) release90 | 30 μl/h | N/A | Merck, Germany Oxygen plasma | 10 μm | 0.4 μm; 15% | Matrigel® and collagen Type I (Calu-3, epithelial) |
PC* | Blood Brain-Barrier: TEER measurements for any organ-on-chip device with two channels separated by a membrane.162 | N/A | N/A | Corning (Transwell ®) PDMS/toluene mortar | 10 μm | 0.4 μm; 15% | Fibronectin (hCMEC/D3) |
PC* | Intestine: Coculture of human and microbial cells under representative conditions Lactobacillus rhamnosus GG, Bacteroides caccae108 | 25 ml/min | N/A | GE Healthcare Gasketing | NS | 1 μm; | Collagen, fibronectin (Caco-2; BeWo trophoblast) |
PC* | Placenta: Screen drug compounds for their ability to cross the placenta Heparin, glyburide40 | Flow rate 100 µl/h. | N/A | GE Healthcare PDMS mortar | NS | 1 μm; | Fibronectin (HPVEC) |